The underlying drivers of Alpha Thalassemia Market growth are multifaceted, rooted in both epidemiological factors and dramatic technological advances in molecular medicine. A primary driver is the persistently high carrier rate—estimated to be around 5% of the global population—in endemic regions such as Southeast Asia, the Middle East, India, and the Mediterranean. This...